Your search history is turned on.
Date: May 6, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - Molecule - Press Release re Receipt of Partial Revocation Order(60053409.4) Molecule Holdings Inc. Announces Issuance of Partial Revocation Order and Further Details Regarding Debenture Amendments and Private Placement May 6, 2024 Molecule Holdings Inc. (CSE: MLCL) (Molecule or the Company), a Canadian craft-focused cannabis beverage product...
Date: May 3, 2024 Jurisdictions: Ontario
Ontario Commission des 22nd Floor 22e tage Securities valeurs mobilires 20 Queen Street West 20, rue queen ouest Commission de lOntario Toronto ON M5H 3S8 Toronto ON M5H 3S8 ______________________________________________________________________________ IN THE MATTER OF MOLECULE HOLDINGS INC. PARTIAL REVOCATION ORDER ...
Date: March 7, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - Molecule - Press Release re CTO Corporate Update and Partial Revocation Application-Mar7 Molecule Holdings Inc. Announces Issuance of Cease Trade Order, Application for Partial Revocation Order, and Provides Update on Debenture Amendments and Financing March 7, 2024 Molecule Holdings Inc. (CSE: MLCL) (Molecule or the Company), a Canadian craft-...
Date: December 28, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - Molecule - 52-109F2 Certificate (Q3 2023) - CFO(55424727.1) (003) Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Andr Audet, as Interim Chief Financial Officer of Molecule Holdings Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim f...
Microsoft Word - Molecule - 52-109F2 Certificate (Q3 2023) - CEO(55424726.1) Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, David Reingold, as Chief Executive Officer of Molecule Holdings Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) o...
Microsoft Word - Molecule - Q3 2023 MDA(55425705.2) MOLECULE HOLDINGS INC. Managements Discussion and Analysis For the three and nine months ended July 31, 2023 Molecule Holdings Inc. Managements Discussion & Analysis For the three and nine months ended July 31, 2023 2 This Managements Discussion and Analysis (MD&A) for Molecule Holdings ...
Molecule Holdings Inc. Notes to the Interim Condensed Consolidated Financial Statements For the three and nine months ended July 31, 2023 (Unaudited - Expressed in Canadian dollars) 1 MOLECULE HOLDINGS INC. Interim Condensed Consolidated Financial Statements For the three and nine months ended July 31, 2023 (Expressed in Canadian Dollars) (Unaud...
Microsoft Word - Molecule - Press Release re CTO Revocation Order and Corporate Update(55444810.1) Molecule Holdings Inc. Announces Revocation of Cease Trade Order and Provides Corporate Update December 28, 2023 Molecule Holdings Inc. (CSE: MLCL) (Molecule or the Company), a Canadian craft- focused cannabis beverage production company, today announces the revo...
Date: November 20, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Microsoft Word - Molecule - Press Release re CFO Resignation and Appointment and Consulting Arrangement-Nov20 Molecule Holdings Inc. Announces Change of Chief Financial Officer November 20, 2023 Molecule Holdings Inc. (CSE: MLCL) (Molecule or the Company), a Canadian craft- focused cannabis beverage production company, today announces that Mr. Jeffrey Stoss has ...
Date: October 6, 2023 Jurisdictions: Alberta, British Columbia, Ontario, Quebec
Molecule - Press Release re MCTO Rejection and Corporate Update-Oct6 Molecule Holdings Inc. Provides Update on Application for Management Cease Trade Order and Corporate Update October 6, 2023 Molecule Holdings Inc. (CSE: MLCL) (Molecule or the Company), a Canadian craft-focused cannabis beverage production company, today announce...